![Thomas Weaver](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Weaver
Fundador en PetMedix Ltd. .
Origen de la red de primer grado Thomas Weaver.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
PetMedix Ltd.
![]() PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom.
6
| Holding Company | Biotechnology | 6 |
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Thomas Weaver a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
University of Oxford | College/University | Doctorate Degree Graduate Degree | |
The Boston Consulting Group, Inc.
![]() The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Consultant / Advisor | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Iowa State University | College/University | Graduate Degree | |
University of Birmingham | College/University | Doctorate Degree | |
Wellcome Trust Sanger Institute
![]() Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Bioindustry Association
![]() The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
SEQUENT SCIENTIFIC LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Novartis Animal Health US, Inc.
![]() Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Novartis Animal Health US, Inc. manufactures pharmaceutical products for animals. The company is based in Greensboro, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Merial LLC | Chief Tech/Sci/R&D Officer | ||
Novartis Consumer Health
![]() Novartis Consumer Health Medical/Nursing ServicesHealth Services Novartis Consumer Health engages in the provision of healthcare services. The company is headquartered in Swaziland. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Investment Managers | Private Equity Investor | |
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member | |
Congenica Ltd.
![]() Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member Chief Investment Officer | |
Syncona Partners LLP
![]() Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Harvard Business School | College/University | Graduate Degree | |
The University of Veterinary Medicine Hanover | College/University | Undergraduate Degree | |
Cambridge Innovation Capital Ltd
![]() Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Analyst | |
C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Chairman | |
Chessington Nurseries Ltd.
![]() Chessington Nurseries Ltd. Agricultural Commodities/MillingProcess Industries Chessington Nurseries Ltd. operates nursery farm. It offers gardening essentials, from seeds to tree, outdoor living, home, leisure, pets, and wildlife, aquatics, and design, build and maintenance services. The company was founded in 1949 and is headquartered in Chessington, the United Kingdom. | Agricultural Commodities/Milling | Director/Board Member | |
Digitalis Ventures LLC
![]() Digitalis Ventures LLC Investment ManagersFinance Digitalis Ventures LLC (Digitalis Ventures) is a venture capital firm founded in 2016 by Geoffrey W. Smith. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Exvastat Ltd.
![]() Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novobind Livestock Therapeutics, Inc.
![]() Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Biotechnology | Consultant / Advisor | |
Chessington Nurseries Holdings Co. Ltd.
![]() Chessington Nurseries Holdings Co. Ltd. Specialty StoresRetail Trade Chessington Nurseries Holdings Co. Ltd. is a retail company founded in 2017. The private company operates retail stores and is based in Chessington, UK. and has subsidiaries in United Kingdom. | Specialty Stores | Director/Board Member | |
Predictimmune Ltd.
![]() Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Bessemer Investors
![]() Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Aleta Biotherapeutics, Inc.
![]() Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
MiroBio Ltd.
![]() MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Pfizer Animal Health
![]() Pfizer Animal Health Pharmaceuticals: MajorHealth Technology Part of Zoetis, Inc., Pfizer Animal Health engages in discovery, development and manufacture of innovative animal vaccines and medicines. The company is based in São Paulo, Brazil. | Pharmaceuticals: Major | Director/Board Member | |
Rejuvenate Bio, Inc.
![]() Rejuvenate Bio, Inc. BiotechnologyHealth Technology Rejuvenate Bio, Inc. operates as a biotechnology company. The company was founded by George Church, Noah Davidsohn and Daniel Oliver is headquartered in San Diego, CA. | Biotechnology | Consultant / Advisor | |
Pheno Therapeutics Ltd.
![]() Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Stonehaven Incubate AG
![]() Stonehaven Incubate AG Financial ConglomeratesFinance Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland. | Financial Conglomerates | Director/Board Member | |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | Biotechnology | Director/Board Member | |
Alsa Management Services Ltd
![]() Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Lifearc Ventures
![]() Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
PERELLA WEINBERG PARTNERS | Investment Banks/Brokers | Corporate Officer/Principal | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
AviadoBio Ltd.
![]() AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Monograph Capital Advisors (UK) LLP
![]() Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Investment Managers | Founder | |
EpiBiologics, Inc.
![]() EpiBiologics, Inc. Miscellaneous Commercial ServicesCommercial Services EpiBiologics, Inc. is an American biotech company that is developing a protein degradation platform to target membrane and extracellular proteins. The company is headquartered in an undisclosed location and is backed by leading healthcare investors. The company is based in San Francisco, CA. EpiBiologics' proprietary epitac platform is an antibody-based system that can precisely degrade disease-driving proteins in a tissue-specific manner. EpiBiologics aims to develop first-in-class and targeted therapies for cancer, immunology, and neurological diseases. The company was founded in 2022 by Dr. Jim Wells of the University of California, San Francisco (UCSF). Ann Lee-Karlon has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
Bonum Therapeutics, Inc.
![]() Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
IONTAS Ltd. (United Kingdom)
![]() IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Biotechnology | Founder | |
The Royal Veterinary College | College/University | Consultant / Advisor |
Estadísticas
Internacional
Reino Unido | 26 |
Estados Unidos | 16 |
India | 2 |
Esuatini | 2 |
Noruega | 2 |
Sectorial
Health Technology | 18 |
Finance | 12 |
Consumer Services | 9 |
Commercial Services | 8 |
Health Services | 2 |
Operativa
Director/Board Member | 45 |
Corporate Officer/Principal | 17 |
Chief Tech/Sci/R&D Officer | 11 |
Founder | 9 |
Private Equity Investor | 9 |
Las relaciones más conectadas
Insiders | |
---|---|
Robert Tansley | 18 |
Eva-Lotta Allan | 17 |
Fabian Kausche | 15 |
Alastair Kilgour | 11 |
Sohaib Mir | 10 |
Tim Funnell | 10 |
Samuel Bjork | 8 |
Allan Bradley | 5 |
Jolyon Martin | 3 |
Lucy Edwardes Jones | 2 |
John McCafferty | 2 |
Aneesh Karatt-Vellatt | 1 |
- Bolsa de valores
- Insiders
- Thomas Weaver
- Conexiones Empresas